Clinical quick reference — print-friendly

Clinical Quick Reference

A short educational summary for clinicians and teams seeing the condition for the first time. Not a treatment protocol and not a substitute for primary literature.

Last reviewed: September 2026No doses · no invented prevalence · no cure claims

Condition identity (educational)

Carbonic anhydrase II deficiency linked to the CA2 gene. Literature may use osteopetrosis with renal tubular acidosis. This page is not a diagnosis.

CA2Recessive inheritanceBoneRTACerebral calcification

When might the differential include CA II?

When reports combine osteopetrosis-like bone findings with renal acid–base/electrolyte disturbance — with referral for genetic and multidisciplinary evaluation. No mandatory checklist here.

Common follow-up themes in the literature (no numbers or doses)

  • Acid–base, bicarbonate, and pH as decided by the clinician
  • Potassium and other electrolytes when indicated
  • Kidney function and growth
  • Bone/fractures, vision, hearing, neurologic/developmental status, and dental care by context

No target values and no dosing tables appear here. Clinical decisions are individualized.

Supportive care — concepts only

The treatment page summarizes acid–base/electrolyte support and organ-focused follow-up. Do not take doses from this page or any general summary.

Treatment & clinical management

HSCT — evidence limits

Limited reports; skeletal disease may improve while RTA may persist. Multidisciplinary assessment — not standard care for all patients.

Do not generalize from other osteopetrosis types

Do not assume therapies used in other osteopetrosis types (e.g., interferon-γ or bisphosphonates as routine CA II care) apply here. See the “do not generalize” section on the treatment page.

Family tools (organization only)

Family care toolkit and this page are educational/organizational. Awareness materials links only existing files.

Links: For clinicians · Sources · Global evidence · Glossary